Search Results 1821-1830 of 4062 for Solid

  1. A Study of Oral Ozanimod as Maintenance Therapy for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

    Subject has had active cancer within 5 years including solid tumors and hematological malignancies (except basal cell and in situ squamous cell carcinomas ...

  2. Infectious Diseases! Clinical Trials - Mayo Clinic Research

    diff infection (CDI) in solid organ transplant (SOT) recipients in a randomized, controlled clinical trial. A Study to Determine the Differences in ...

  3. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

    * Has had an allogeneic tissue/solid organ transplant * Participants with an active autoimmune disease requiring systemic treatment. Participants with ...

  4. Clinical trials - Oncology (Medical)

    ... solid tumor patients. A Study To Evaluate Oncologic Outcomes And Quality Of Life In Sinonasal Cancer Patients. Rochester, Minn. This is a multi-site study ...

  5. Lipogems-processed Microfragmented Adipose Tissue Compared to Saline for the Treatment of Knee Osteoarthritis - Mayo Clinic

    History of solid organ or hematologic transplantation;; Diagnosis of non-basal cell malignancy within preceding 5 years;; Change in prescription medication ...

  6. Leukemia Clinical Trials - Mayo Clinic Research

    The purpose of this study is to evaluate the side effects and how well larotrectinib works in treating patients with previously untreated TRK fusion solid ...

  7. A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

    Has had an allogenic tissue/solid organ transplant. A WOCBP who has a positive urine pregnancy test within 24 hours before the first dose of study treatment ...

  8. Olaparib and Cediranib Maleate in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    Participants must have measurable disease via Response Evaluation Criteria in Solid Tumors (RECIST) 1.1, defined as at least one lesion that can be ...

  9. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

    No prior allogeneic tissue/solid organ transplant. No uncontrolled intercurrent illness including, but not limited to, serious ongoing or active infection ...

  10. Publications - Ying-Chun Lo, M.D., Ph.D. - Mayo Clinic

    Molecular profiling identifies targeted therapy opportunities in pediatric solid cancer. Nat Med. 2022 Aug; 28 (8):1581-1589 Epub 2022 June 23. View PubMed ...